This department is providing funding to support the Cancer Immunotherapy Trials Network (CITN) in designing and conducting multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients. The grants will be used to explore the use of novel immunomodulatory agents in cancer treatment, with the ultimate goal of advancing research in this field. The closing date for applications is Mar 10, 2017.
Opportunity ID: 290332
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-501 |
| Funding Opportunity Title: | Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Nov 25, 2016 |
| Last Updated Date: | Jan 27, 2017 |
| Original Closing Date for Applications: | Jan 24, 2017 |
| Current Closing Date for Applications: | Mar 10, 2017 |
| Archive Date: | Apr 09, 2017 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated funding information in accordance with NOT-CA-17-021 | Jan 27, 2017 | |
| Updated expiration date in accordance with NOT-CA-17-017 | Jan 27, 2017 | |
| Jan 11, 2017 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-501 |
| Funding Opportunity Title: | Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Nov 25, 2016 |
| Last Updated Date: | Jan 27, 2017 |
| Original Closing Date for Applications: | Jan 24, 2017 |
| Current Closing Date for Applications: | Mar 10, 2017 |
| Archive Date: | Apr 09, 2017 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-501 |
| Funding Opportunity Title: | Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 27, 2017 |
| Last Updated Date: | Jan 11, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 10, 2017 |
| Archive Date: | Apr 09, 2017 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-501 |
| Funding Opportunity Title: | Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 11, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 24, 2017 |
| Archive Date: | Feb 24, 2017 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00229446 | Dec 24, 2016 | Mar 10, 2017 | View |
Package 1
Mandatory forms
290332 RR_SF424_2_0-2.0.pdf
290332 PHS398_CoverPageSupplement_3_0-3.0.pdf
290332 RR_OtherProjectInfo_1_3-1.3.pdf
290332 PerformanceSite_2_0-2.0.pdf
290332 RR_KeyPersonExpanded_2_0-2.0.pdf
290332 RR_Budget_1_3-1.3.pdf
290332 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
290332 RR_SubawardBudget30_1_3-1.3.pdf
290332 PHS_Inclusion_Enrollment_Report-1.0.pdf
290332 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
